Literature DB >> 25512785

Risks of rapid decline renal function in patients with type 2 diabetes.

Yi-Jing Sheen1, Wayne Hh Sheu1.   

Abstract

Progressive rising population of diabetes and related nephropathy, namely, diabetic kidney disease and associated end stage renal disease has become a major global public health issue. Results of observational studies indicate that most diabetic kidney disease progresses over decades; however, certain diabetes patients display a rapid decline in renal function, which may lead to renal failure within months. Although the definition of rapid renal function decline remained speculative, in general, it is defined by the decrease of estimated glomerular filtration rate (eGFR) in absolute rate of loss or percent change. Based on the Kidney Disease: Improving Global Outcomes 2012 clinical practice guidelines, a rapid decline in renal function is defined as a sustained decline in eGFR of > 5 mL/min per 1.73 m(2) per year. It has been reported that potential factors contributing to a rapid decline in renal function include ethnic/genetic and demographic causes, smoking habits, increased glycated hemoglobin levels, obesity, albuminuria, anemia, low serum magnesium levels, high serum phosphate levels, vitamin D deficiency, elevated systolic blood pressure, pulse pressure, brachial-ankle pulse wave velocity values, retinopathy, and cardiac autonomic neuropathy. This article reviews current literatures in this area and provides insight on the early detection of diabetic subjects who are at risk of a rapid decline in renal function in order to develop a more aggressive approach to renal and cardiovascular protection.

Entities:  

Keywords:  Albuminuria; Diabetic kidney disease; Estimated glomerular filtration rate; Rapid decline; Type 2 diabetes

Year:  2014        PMID: 25512785      PMCID: PMC4265869          DOI: 10.4239/wjd.v5.i6.835

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  117 in total

1.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.

Authors:  P Gaede; P Vedel; H H Parving; O Pedersen
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

2.  Urine volume and change in estimated GFR in a community-based cohort study.

Authors:  William F Clark; Jessica M Sontrop; Jennifer J Macnab; Rita S Suri; Louise Moist; Marina Salvadori; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

3.  Impaired left ventricular systolic function and increased brachial-ankle pulse-wave velocity are independently associated with rapid renal function progression.

Authors:  Szu-Chia Chen; Tsung-Hsien Lin; Po-Chao Hsu; Jer-Ming Chang; Chee-Siong Lee; Wei-Chung Tsai; Ho-Ming Su; Wen-Chol Voon; Hung-Chun Chen
Journal:  Hypertens Res       Date:  2011-07-14       Impact factor: 3.872

4.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

Review 5.  The RAAS in the pathogenesis and treatment of diabetic nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

6.  Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.

Authors:  Atsuyuki Shimazaki; Yoshihiro Kawamura; Akio Kanazawa; Akihiro Sekine; Susumu Saito; Tatsuhiko Tsunoda; Daisuke Koya; Tetsuya Babazono; Yasushi Tanaka; Masafumi Matsuda; Koichi Kawai; Tomohiro Iiizumi; Masahito Imanishi; Toshihiro Shinosaki; Toru Yanagimoto; Minoru Ikeda; Shigeki Omachi; Atsunori Kashiwagi; Kohei Kaku; Yasuhiko Iwamoto; Ryuzou Kawamori; Ryuichi Kikkawa; Masatoshi Nakajima; Yusuke Nakamura; Shiro Maeda
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

7.  Renal insufficiency without albuminuria is associated with peripheral artery atherosclerosis and lipid metabolism disorders in patients with type 2 diabetes.

Authors:  Takahiro Yamashita; Hisashi Makino; Rieko Nakatani; Yoko Ohata; Yoshihiro Miyamoto; Ichiro Kishimoto
Journal:  J Atheroscler Thromb       Date:  2013-07-25       Impact factor: 4.928

8.  Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.

Authors:  Sherifa Ahmed Hamed; Nabila F Amine; Ghada M Galal; Shaaban R Helal; Lubna M Tag El-Din; Ola A Shawky; Eman A Ahmed; Mohamed S Abdel Rahman
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Mar-Apr       Impact factor: 2.136

Review 9.  Blood glucose and lipid control as risk factors in the progression of renal damage in type 2 diabetes.

Authors:  Romano Nosadini; Giancarlo Tonolo
Journal:  J Nephrol       Date:  2003 Nov-Dec       Impact factor: 3.902

10.  Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.

Authors:  Ting-Yuan David Cheng; Sung-Feng Wen; Brad C Astor; Xuguang Grant Tao; Jonathan M Samet; Chi Pang Wen
Journal:  Am J Kidney Dis       Date:  2008-08-15       Impact factor: 8.860

View more
  16 in total

1.  Structural Predictors of Renal Function Decline.

Authors:  Susanne B Nicholas
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-20       Impact factor: 8.237

2.  Effects of various stages of nephropathy on wound healing in patients with diabetes: an observational cohort study encompassing 731 diabetics.

Authors:  Paula Loewe; Ioannis Stefanidis; Peter R Mertens; Christos Chatzikyrkou
Journal:  Int Urol Nephrol       Date:  2016-02-12       Impact factor: 2.370

3.  Relationships Between Metabolic Body Composition Status and Rapid Kidney Function Decline in a Community-Based Population: A Prospective Observational Study.

Authors:  Shao-Chi Chu; Po-Hsi Wang; Kuan-Ying Lu; Chia-Chun Ko; Yun-Hsuan She; Chin-Chan Lee; I-Wen Wu; Chiao-Yin Sun; Heng-Jung Hsu; Heng-Chih Pan
Journal:  Front Public Health       Date:  2022-06-03

4.  [Diabetic nephropathy: current diagnostics and treatment].

Authors:  S Werth; H Lehnert; J Steinhoff
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

Review 5.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Authors:  Merlin C Thomas; Mark E Cooper; Paul Zimmet
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

Review 6.  Impact of Mediterranean diet on metabolic syndrome, cancer and longevity.

Authors:  Nicola Di Daniele; Annalisa Noce; Maria Francesca Vidiri; Eleonora Moriconi; Giulia Marrone; Margherita Annicchiarico-Petruzzelli; Gabriele D'Urso; Manfredi Tesauro; Valentina Rovella; Antonino De Lorenzo
Journal:  Oncotarget       Date:  2017-01-31

7.  Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus.

Authors:  Kyung Soo Kim; Seok Won Park; Yong Wook Cho; Soo Kyung Kim
Journal:  Diabetes Metab J       Date:  2018-05-31       Impact factor: 5.376

8.  Relationship between kidney function decline and initial risk factors for the progression of diabetic kidney disease: a retrospective analysis of 91 Japanese patients with type 2 diabetes.

Authors:  Toshiharu Ishizuka; Yoshiharu Tokuyama; Atsuya Horie; Yukiko Hatanaka; Sumihiko Sato; Azuma Kanatsuka
Journal:  Diabetol Int       Date:  2016-05-03

9.  Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats.

Authors:  Shu-Zhi Wang; Yin-Li Xu; Qi Zhu; Jian-Qun Kou; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-11       Impact factor: 2.629

10.  Exercise-induced albuminuria and circadian blood pressure abnormalities in type 2 diabetes.

Authors:  Aurel T Tankeu; François Folefack Kaze; Jean Jacques Noubiap; David Chelo; Mesmin Yefou Dehayem; Eugene Sobngwi
Journal:  World J Nephrol       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.